ABBV vs UTHR

AbbVie Inc. (ABBV) is a well-established mega-cap pharmaceutical company with a robust product portfolio, strong financial health, and a leading position in key therapeutic areas. It excels as a stable dividend payer and a defensive holding. However, its fundamental characteristics, including its immense market capitalization ($397.29B), the mature nature of the pharmaceutical industry, high R&D c...

United Therapeutics continues to build on its strong foundation in rare pulmonary diseases with significant recent wins. The TETON-1 pivotal study success for Tyvaso in IPF substantially expands its addressable market and derisks future revenue streams from its core business. Furthermore, the FDA's RMAT designation for miroliverELAP provides a positive signal for its ambitious regenerative medicin...